NSE filing, NSE: AMRUTANJAN. Summary written from the filing by ALFA Finder's alert engine.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹496.65
- Market cap
- ₹1,436 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 26.6×Sector 45.9×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Board Meeting Date
Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.
Amrutanjan Health Care Other Announcement
Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
- Value
- ₹0.06 Cr
Amrutanjan Health Care Business Update
Amrutanjan Health Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. This disclosure forms part of the company's Annual Report requirements.
Other employee stock options announcements
All →Niva Bupa Health Insurance Company Employee Stock Options
Niva Bupa allotted 9,89,450 equity shares to employees on exercise of ESOP options under its 2020 and 2024 schemes. Paid-up capital rose to Rs. 18,50,63,41,530.
Meesho Employee Stock Options
Meesho allotted 21,43,590 equity shares to employees on exercise of ESOP 2024 options. No exercise price or consideration is disclosed in the filing.
Studds Accessories Employee Stock Options
Studds Accessories granted 1,30,000 ESOPs to eligible employees under its 2026 scheme at an exercise price of Rs 334.90. Options vest over time, converting to equity shares on exercise.
Poonawalla Fincorp Employee Stock Options
Poonawalla Fincorp allotted 30,773 equity shares under its employee stock option schemes on 31 October 2026. The shares rank pari passu with existing equity.
Eveready Industries India Employee Stock Options
Eveready Industries granted 48,000 stock options to eligible employees under its ESOP 2026 plan, approved by the NRC on 31 October 2026. The filing is an employee stock option grant intimation with no cash consideration stated.
Max Estates Employee Stock Options
Max Estates allotted 632 equity shares to an option holder under its ESOP Plan 2023. The allotment raises paid-up capital; no transaction price is stated.